OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,595,000 | -23.2% | 370,900 | -90.0% | 0.08% | -39.9% |
| Q1 2016 | $2,077,000 | -67.4% | 3,709,000 | 0.0% | 0.14% | -66.0% |
| Q4 2015 | $6,379,000 | -18.5% | 3,709,000 | 0.0% | 0.41% | -21.3% |
| Q3 2015 | $7,826,000 | -57.4% | 3,709,000 | 0.0% | 0.52% | -46.2% |
| Q2 2015 | $18,360,000 | -36.8% | 3,709,000 | 0.0% | 0.96% | -27.0% |
| Q1 2015 | $29,041,000 | +29.2% | 3,709,000 | 0.0% | 1.31% | +20.5% |
| Q4 2014 | $22,477,000 | +42.3% | 3,709,000 | 0.0% | 1.09% | +35.7% |
| Q3 2014 | $15,800,000 | +32.1% | 3,709,000 | +91.6% | 0.80% | +43.1% |
| Q2 2014 | $11,960,000 | -4.9% | 1,935,300 | 0.0% | 0.56% | -9.2% |
| Q1 2014 | $12,579,000 | +15.4% | 1,935,300 | 0.0% | 0.62% | +17.5% |
| Q4 2013 | $10,896,000 | +53.9% | 1,935,300 | +67.5% | 0.53% | +87.2% |
| Q3 2013 | $7,082,000 | – | 1,155,300 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |